Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ludwig

Showing results (151-160 of 231) with videos related to

Pageof 24
Sort By:
Vaccines|June 27, 2025
SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease PatientsEva Ulla Lorentzen, Richard Vollenberg, Rieke Neddermeyer, et al.
The Journal of Biological Chemistry|June 17, 2010
Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4)Nils Ohnesorge, Dorothee Viemann, Nicole Schmidt, et al.
Glycobiology|April 27, 2012
The human H3N2 influenza viruses A/Victoria/3/75 and A/Hiroshima/52/2005 preferentially bind to α2-3-sialylated monosialogangliosides with fucosylated poly-N-acetyllactosaminyl chainsIris Meisen, Tabea Dzudzek, Christina Ehrhardt, et al.
Oncoimmunology|May 4, 2018
Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophagesDörthe Masemann, Katharina Köther, Meike Kuhlencord, et al.
Oncogene|July 6, 2004
Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected miceVeronika Olschläger, Stephan Pleschka, Timo Fischer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2021
Small spleen peptides prevent development of psoriatic arthritis via restoration of peripheral toleranceViktor Wixler, Igor Z Zaytsev, Rafael Leite Dantas, et al.
Cellular Microbiology|December 22, 2015
Phosphorylation of influenza A virus NS1 protein at threonine 49 suppresses its interferon antagonistic activityOmer Abid Kathum, Tobias Schräder, Darisuren Anhlan, et al.
Journal of Virology|October 9, 2002
The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factorsStephan Ludwig, Xiuyan Wang, Christina Ehrhardt, et al.
Fitoterapia|May 15, 2025
Antiviral activity against HSV-1 of triterpene saponins from Anagallis arvensis is related tothe fusion-inhibitory activity of desglucoanagalloside BNica Classen, Jandirk Sendker, Diana Ulrich, et al.
Cellular Microbiology|March 3, 2021
Nonsense-mediated mRNA decay does not restrict influenza A virus propagationGiao Vu Quynh Tran, Jens Kleinehr, Hannah Franziska Preugschas, et al.
Pageof 24

Showing results (151-160 of 231) with videos related to

Sort By:
Pageof 24
Vaccines|June 27, 2025
SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease PatientsEva Ulla Lorentzen, Richard Vollenberg, Rieke Neddermeyer, et al.
The Journal of Biological Chemistry|June 17, 2010
Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4)Nils Ohnesorge, Dorothee Viemann, Nicole Schmidt, et al.
Glycobiology|April 27, 2012
The human H3N2 influenza viruses A/Victoria/3/75 and A/Hiroshima/52/2005 preferentially bind to α2-3-sialylated monosialogangliosides with fucosylated poly-N-acetyllactosaminyl chainsIris Meisen, Tabea Dzudzek, Christina Ehrhardt, et al.
Oncoimmunology|May 4, 2018
Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophagesDörthe Masemann, Katharina Köther, Meike Kuhlencord, et al.
Oncogene|July 6, 2004
Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected miceVeronika Olschläger, Stephan Pleschka, Timo Fischer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2021
Small spleen peptides prevent development of psoriatic arthritis via restoration of peripheral toleranceViktor Wixler, Igor Z Zaytsev, Rafael Leite Dantas, et al.
Cellular Microbiology|December 22, 2015
Phosphorylation of influenza A virus NS1 protein at threonine 49 suppresses its interferon antagonistic activityOmer Abid Kathum, Tobias Schräder, Darisuren Anhlan, et al.
Journal of Virology|October 9, 2002
The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factorsStephan Ludwig, Xiuyan Wang, Christina Ehrhardt, et al.
Fitoterapia|May 15, 2025
Antiviral activity against HSV-1 of triterpene saponins from Anagallis arvensis is related tothe fusion-inhibitory activity of desglucoanagalloside BNica Classen, Jandirk Sendker, Diana Ulrich, et al.
Cellular Microbiology|March 3, 2021
Nonsense-mediated mRNA decay does not restrict influenza A virus propagationGiao Vu Quynh Tran, Jens Kleinehr, Hannah Franziska Preugschas, et al.
Pageof 24